and Their Regulation by Nitric Oxide Biological Roles of Acid and Neutral Sphingomyelinases
暂无分享,去创建一个
S. Richard | E. Clementi | S. Cuzzocrea | L. Obeid | I. Petrache | M. Elliott | E. Esposito | P. Hopkins | J. Little | A. Snider | G. Nicol | W. Neumann | K. Janes | A. Eckerd | T. Doyle | Zhoumou Chen | Julie-Thu A. Tran | Collin L. Chen | L. Bryant | Hui Chen | Tuan-Phat Huynh | Chao Li | Kali Janes | Leesa Bryant
[1] E. Clementi,et al. Acid sphingomyelinase activity triggers microparticle release from glial cells , 2009, The EMBO journal.
[2] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[3] E. Clementi,et al. Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection , 2008, Journal of neurochemistry.
[4] Petra Schwille,et al. Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.
[5] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[6] Luigi Biancone,et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. , 2007, Blood.
[7] E. Clementi,et al. Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. , 2007, Cancer research.
[8] E. Gulbins,et al. Biological aspects of ceramide-enriched membrane domains. , 2007, Progress in lipid research.
[9] Chunbo Wang,et al. Nitric oxide-enhanced caspase-3 and acidic sphingomyelinase interaction: a novel mechanism by which airway epithelial cells escape ceramide-induced apoptosis. , 2007, Experimental cell research.
[10] A. Futerman. Intracellular trafficking of sphingolipids: relationship to biosynthesis. , 2006, Biochimica et biophysica acta.
[11] Shiyong Wu,et al. Lipid Rafts Mediate Ultraviolet Light–induced Fas Aggregation in M624 Melanoma Cells , 2006, Photochemistry and photobiology.
[12] F. Mollinedo,et al. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[13] E. Clementi,et al. Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor α Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors: A Novel Pathway Relevant to the Pathophysiology of Endothelium , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[14] E. Labelle,et al. Nitric oxide stimulated vascular smooth muscle cells undergo apoptosis induced in part by arachidonic acid derived eicosanoids , 2005, Journal of cellular physiology.
[15] S. Spiegel,et al. Ceramide 1-Phosphate, a Mediator of Phagocytosis* , 2005, Journal of Biological Chemistry.
[16] Z. Fuks,et al. Caspase-dependent and -independent Activation of Acid Sphingomyelinase Signaling* , 2005, Journal of Biological Chemistry.
[17] T. Möller,et al. Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.
[18] E. Clementi,et al. Activation of Acid Sphingomyelinase and Its Inhibition by the Nitric Oxide/Cyclic Guanosine 3′,5′-Monophosphate Pathway: Key Events in Escherichia coli-Elicited Apoptosis of Dendritic Cells1 , 2004, The Journal of Immunology.
[19] Jacek Bielawski,et al. Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells* , 2004, Journal of Biological Chemistry.
[20] E. Labelle,et al. NO induced apoptosis of vascular smooth muscle cells accompanied by ceramide increase , 2004, Journal of cellular physiology.
[21] R. Kolesnick,et al. Raft ceramide in molecular medicine , 2003, Oncogene.
[22] Bernhard Brüne,et al. Nitric oxide: NO apoptosis or turning it ON? , 2003, Cell Death and Differentiation.
[23] Wenzheng Zhang,et al. Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. , 2003, American journal of physiology. Renal physiology.
[24] Zvi Fuks,et al. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.
[25] T. Hla. Signaling and biological actions of sphingosine 1-phosphate. , 2003, Pharmacological research.
[26] Y. Hannun,et al. Biochemical Properties of Mammalian Neutral Sphingomyelinase2 and Its Role in Sphingolipid Metabolism* , 2003, The Journal of Biological Chemistry.
[27] E. Clementi,et al. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3' kinase, and Akt. , 2003, Molecular pharmacology.
[28] K. Preissner,et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] P. Oh,et al. Transient Mechanoactivation of Neutral Sphingomyelinase in Caveolae to Generate Ceramide* , 2003, The Journal of Biological Chemistry.
[30] Gianluca Damonte,et al. Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis. , 2003, Molecular pharmacology.
[31] C. Hetz,et al. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase , 2002, Journal of Cell Science.
[32] A. de Thonel,et al. Overexpression of Protein Kinase C (cid:1) Confers Protection Against Antileukemic Drugs by Inhibiting the Redox-Dependent Sphingomyelinase Activation , 2002 .
[33] F. Goñi,et al. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? , 2002, FEBS letters.
[34] R. Borges,et al. Pharmacological Regulation of the Late Steps of Exocytosis , 2002, Annals of the New York Academy of Sciences.
[35] Alfred H. Merrill,et al. De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.
[36] Yusuf A. Hannun,et al. The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind* , 2002, The Journal of Biological Chemistry.
[37] G. Salido,et al. Effect of sodium nitroprusside and 8‐bromo cyclic GMP on nerve‐mediated and acetylcholine‐evoked secretory responses in the rat pancreas , 2002, British journal of pharmacology.
[38] E. Giordano,et al. Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] B. Kemp,et al. Localization of Endothelial Nitric-oxide Synthase Phosphorylated on Serine 1179 and Nitric Oxide in Golgi and Plasma Membrane Defines the Existence of Two Pools of Active Enzyme* , 2002, The Journal of Biological Chemistry.
[40] K. Hirata,et al. Involvement of Endothelial Nitric Oxide in Sphingosine-1-Phosphate–Induced Angiogenesis , 2001 .
[41] W. Sessa,et al. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? , 2001, The Journal of pharmacology and experimental therapeutics.
[42] C. Cooper,et al. Nitric oxide synthases: structure, function and inhibition , 2001 .
[43] O. Cuvillier,et al. Involvement of FAN in TNF-induced apoptosis. , 2001, The Journal of clinical investigation.
[44] I. Shiojima,et al. Sphingosine 1-Phosphate Activates Akt, Nitric Oxide Production, and Chemotaxis through a GiProtein/Phosphoinositide 3-Kinase Pathway in Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[45] T. Billiar,et al. Sphingosine 1-Phosphate Protects Human Umbilical Vein Endothelial Cells from Serum-deprived Apoptosis by Nitric Oxide Production* , 2001, The Journal of Biological Chemistry.
[46] E. Clementi,et al. Activation of the Endothelial Nitric-oxide Synthase by Tumor Necrosis Factor-α , 2001, The Journal of Biological Chemistry.
[47] S. Menéndez,et al. Cell Autonomous Apoptosis Defects in Acid Sphingomyelinase Knockout Fibroblasts* , 2001, The Journal of Biological Chemistry.
[48] A. Quest,et al. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] T. Michel,et al. Agonist-modulated Targeting of the EDG-1 Receptor to Plasmalemmal Caveolae , 2000, The Journal of Biological Chemistry.
[50] S. Jung,et al. Identification of Multiple Forms of Membrane‐Associated Neutral Sphingomyelinase in Bovine Brain , 2000, Journal of neurochemistry.
[51] Deborah A. Brown,et al. Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts* , 2000, The Journal of Biological Chemistry.
[52] W. Stoffel,et al. Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[53] E. Clementi,et al. Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[54] K. Sandhoff,et al. Purification and Characterization of a Magnesium-dependent Neutral Sphingomyelinase from Bovine Brain* , 2000, The Journal of Biological Chemistry.
[55] Y. Hannun,et al. Function of the Cloned Putative Neutral Sphingomyelinase as Lyso-platelet Activating Factor-Phospholipase C* , 1999, The Journal of Biological Chemistry.
[56] J. Stamler,et al. NO: an inhibitor of cell death , 1999, Cell Death and Differentiation.
[57] E. Clementi,et al. Generation of Nitric Oxide by the Inducible Nitric Oxide Synthase Protects γδ T Cells from Mycobacterium tuberculosis-Induced Apoptosis , 1999, The Journal of Immunology.
[58] J. Ahn,et al. TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. , 1999, Journal of immunology.
[59] V. Briner,et al. Nitric oxide stimulates chronic ceramide formation in glomerular endothelial cells. , 1999, Biochemical and biophysical research communications.
[60] T. Uchiyama,et al. Ceramide Generation in Nitric Oxide-induced Apoptosis , 1999, The Journal of Biological Chemistry.
[61] J. Jaffrezou,et al. Signalling sphingomyelinases: which, where, how and why? , 1999, Biochimica et biophysica acta.
[62] B. Liu,et al. Purification and Characterization of a Membrane Bound Neutral pH Optimum Magnesium-dependent and Phosphatidylserine-stimulated Sphingomyelinase from Rat Brain* , 1998, The Journal of Biological Chemistry.
[63] Y. Hannun,et al. The role of ceramide in cell signaling. , 1998, Biochimica et biophysica acta.
[64] W. Stoffel,et al. Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus Coccidioides immitis , 1998 .
[65] M. Krönke,et al. TNF Receptor Death Domain-associated Proteins TRADD and FADD Signal Activation of Acid Sphingomyelinase* , 1998, The Journal of Biological Chemistry.
[66] T. Meyer,et al. Acidic Sphingomyelinase Mediates Entry of N. gonorrhoeae into Nonphagocytic Cells , 1997, Cell.
[67] E. Clementi,et al. Autocrine Nitric Oxide Modulates CD95-induced Apoptosis in γδ T Lymphocytes* , 1997, The Journal of Biological Chemistry.
[68] Y. Hannun,et al. Phospholipase A2 Is Necessary for Tumor Necrosis Factor α-induced Ceramide Generation in L929 Cells* , 1997, The Journal of Biological Chemistry.
[69] Y. Hannun,et al. Cytokine Response Modifier A (CrmA) Inhibits Ceramide Formation in Response to Tumor Necrosis Factor (TNF)-α: CrmA and Bcl-2 Target Distinct Components in the Apoptotic Pathway , 1997, The Journal of experimental medicine.
[70] Seamus J. Martin,et al. Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.
[71] G. Garcı́a-Cardeña,et al. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[72] D. Bredt,et al. Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.
[73] A. Bielawska,et al. Role of Ceramide in Cellular Senescence (*) , 1995, The Journal of Biological Chemistry.
[74] D. Perl,et al. Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease , 1995, Nature Genetics.
[75] W. Stoffel,et al. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease) , 1995, Cell.
[76] K. Sandhoff,et al. Occurrence of two molecular forms of human acid sphingomyelinase. , 1994, The Biochemical journal.
[77] K. Sandhoff,et al. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. , 1994, Biological chemistry Hoppe-Seyler.
[78] K. Sandhoff,et al. Processing of human acid sphingomyelinase in normal and I-cell fibroblasts. , 1994, The Journal of biological chemistry.
[79] Y. Hannun,et al. Programmed cell death induced by ceramide. , 1993, Science.
[80] R. Desnick,et al. Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). , 1992, Genomics.
[81] R. Salvayre,et al. Different pathways of uptake and degradation of sphingomyelin by lymphoblastoid cells and the potential participation of the neutral sphingomyelinase. , 1991, The Journal of biological chemistry.
[82] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[83] A. Bielawska,et al. Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. , 1990, The Journal of biological chemistry.
[84] Y. Hannun,et al. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. , 1989, The Journal of biological chemistry.
[85] R. Kolesnick. Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells. , 1989, The Journal of biological chemistry.
[86] R. Kolesnick. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. , 1987, The Journal of biological chemistry.
[87] M. Berridge. Inositol trisphosphate and diacylglycerol as second messengers. , 1984, The Biochemical journal.
[88] E. P. Kennedy,et al. Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. , 1967, Journal of lipid research.
[89] R. Kolesnick,et al. Acid sphingomyelinase-derived ceramide signaling in apoptosis. , 2002, Sub-cellular biochemistry.
[90] D. Kabelitz,et al. Ceramide: does it matter for T cells? , 2002, Trends in immunology.
[91] J. Dichgans,et al. Fas/CD95/Apo-I activates the acidic sphingomyelinase via Caspases , 1998, Cell Death and Differentiation.
[92] E. Schuchman,et al. Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis. , 1997, European journal of biochemistry.